Fundz

Oryon Cell Therapies Appoints Ron Cohen, M.D. as Chief Executive Officer

PRIVATEMar 23, 2026

Position

Chief Executive Officer

Company

Oryon Cell Therapies

Ron Cohen, M.D.
BiotechnologyHealth CareTherapeutics

Description

Oryon Cell Therapies has appointed Ron Cohen, M.D., as Chief Executive Officer to lead the company in developing therapies for Parkinson's disease. The appointment comes alongside the announcement of a new financing tranche of $21 million.

Quick answer

Oryon Cell Therapies Appoints Ron Cohen, M.D. as Chief Executive Officer (March 23, 2026).

Who is the new Chief Executive Officer at Oryon Cell Therapies?
Oryon Cell Therapies named Ron Cohen, M.D. Chief Executive Officer, announced March 23, 2026.
What did Oryon Cell Therapies announce on March 23, 2026?
Oryon Cell Therapies has appointed Ron Cohen, M.D., as Chief Executive Officer to lead the company in developing therapies for Parkinson's disease. The appointment comes alongside the announcement of a new financing tranche of $21 million.
What does Oryon Cell Therapies do?
Oryon Cell Therapies is a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders.
Which similar companies made leadership changes around the same time?
TuHURA Biosciences (March 23, 2026), Aurinia Pharma (March 23, 2026), Amani Therapeutics (March 23, 2026) and Vera Therapeutics, Inc. (March 25, 2026) also announced leadership changes within 45 days of Oryon Cell Therapies.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Oryon Cell Therapies, and when

A new leader at Oryon Cell Therapies brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Oryon Cell Therapies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Oryon Cell Therapies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Oryon Cell Therapies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Oryon Cell Therapies

About

Oryon Cell Therapies is a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders. The company's lead therapy aims to restore dopaminergic function in patients' brains. Oryon has made significant progress in transitioning their technology from the lab to clinical trials. Their approach utilizes patients' own blood cells to create replacement neurons, eliminating the need for immune suppression.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Oryon Cell Therapies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Oryon Cell Therapies's next move

Learn about Strategic plan

Oryon Cell Therapies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.